Company Filing History:
Years Active: 2021
Title: Chih-Chuan Chang: Innovator in Receptor Research
Introduction
Chih-Chuan Chang is a prominent inventor based in Beijing, China. He has made significant contributions to the field of receptor research, particularly with his work on the MIC-1 receptor.
Latest Patents
Chih-Chuan Chang holds a patent for the MIC-1 receptor and its uses. The patent details the newly identified MIC-1 binding receptor, GFRAL. It also includes in vitro bioassays for testing the affinity and potency of GFRAL ligands, such as MIC-1 or its variants. This innovation is crucial for advancing therapeutic applications.
Career Highlights
Chih-Chuan Chang is currently employed at Novo Nordisk A/S, where he continues to explore the potential of receptor biology. His work has implications for various medical fields, including metabolic disorders and cancer research.
Collaborations
Chih-Chuan has collaborated with notable colleagues, including Jing Su and Wei Yang. Their combined expertise enhances the research and development efforts at Novo Nordisk A/S.
Conclusion
Chih-Chuan Chang's contributions to receptor research and his innovative patent on the MIC-1 receptor highlight his role as a leading inventor in the field. His work continues to pave the way for advancements in medical science.